IP Library Granted Patent US 7,244,724
Granted Patent B2
US 7,244,724 · App. 11/129,207 · Granted Jul 17, 2007

Pyrrolobenzodiazepines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,244,724
App. No.
11/129,207
Granted
Jul 17, 2007
Kind
B2
Abstract

A compound of formula I: or solvate thereof, wherein n is 1 to 10, and M and M′ are independently selected from monovalent pharmaceutically acceptable cations, or together represent a divalent pharmaceutically acceptable cation.

Claims (15)

1. A compound of formula I:

wherein n is 1 to 10, and M and M′ are independently selected from monovalent pharmaceutically acceptable cations, or together represent a divalent pharmaceutically acceptable cation.

2. A compound according to claim 1 , wherein n is 1, 3, 6, 7 or 8.

3. A compound according to claim 2 , wherein n is 1 or 3.

4. The compound according to claim 1 , wherein M and M′ are the same.

5. The compound according to claim 4 , wherein each of M and M′ is an alkali metal ion.

6. The compound according to claim 5 , wherein each of M and M′ is Na + .

7. The compound of claim 1 , wherein the compound is purified or isolated.

8. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

9. A pharmaceutical composition comprising the compound of claim 2 and a pharmaceutically acceptable carrier.

10. A pharmaceutical composition comprising the compound of claim 3 and a pharmaceutically acceptable carrier.

11. A pharmaceutical composition comprising the compound of claim 4 and a pharmaceutically acceptable carrier.

12. A pharmaceutical composition comprising the compound of claim 5 and a pharmaceutically acceptable carrier.

13. A pharmaceutical composition comprising the compound of claim 6 and a pharmaceutically acceptable carrier.

14. A pharmaceutical composition comprising the compound of claim 7 and a pharmaceutically acceptable carrier.

Assignments (1)
CONFIRMATORY ASSIGNMENT OF SHARE Recorded Mar 20, 2017
From: SPIROGEN SARL
To: MEDIMMUNE LIMITED
Reel/Frame 041652/0163 →